Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors
post
Last Updated: April 2, 2026, 4:06 am
Author: Getaka|Social: XLinkedIn
Stock Ticker - BSE: 506260 | NSE: ANUHPHR

Anuh Pharma Ltd: Intrinsic Value & Share Price Analysis

Fair Value

₹62.42Overvalued by 14.49%vs CMP ₹73.00

P/E (17.5) × ROE (13.4%) × BV (₹32.60) × DY (2.06%)

₹53.65Overvalued by 26.51%vs CMP ₹73.00
MoS: -36.1% (Negative)Confidence: 62/100 (Moderate)Models: 3 Fair, 7 Over
ModelCategoryValueWeightSignal
PE-ROEEarnings₹66.4520%Fair (-9%)
Graham NumberEarnings₹55.3114%Over (-24.2%)
Earnings PowerEarnings₹39.3912%Over (-46%)
DCFCash Flow₹60.3612%Over (-17.3%)
Net Asset ValueAssets₹32.666%Over (-55.3%)
EV/EBITDAEnterprise₹70.908%Fair (-2.9%)
Dividend DiscountDividends₹28.808%Over (-60.5%)
Earnings YieldEarnings₹41.706%Over (-42.9%)
ROCE CapitalReturns₹56.418%Over (-22.7%)
Revenue MultipleRevenue₹66.115%Fair (-9.4%)
Consensus (10 models)₹53.65100%Overvalued

PE-ROE · Graham · EPV · DCF · NAV · EV/EBITDA · DDM · Earnings Yield · ROCE Capital · Revenue Multiple | CoE: 12% · Terminal: 4% · EPS CAGR: 6.5%

*Investments are subject to market risks

Investment Snapshot

64
Anuh Pharma Ltd scores 64/100 (Average)
Based on 5 dimensions: health, institutional flow, earnings quality, momentum, and peer comparison
Stock Health81/100 · Strong
ROCE 17.2% GoodROE 13.4% GoodD/E 0.07 Low debtInterest Coverage 0.0x RiskyProfitable 5/5 years Consistent
Smart Money50/100 · Moderate
FII holding stable No changePromoter holding at 71.8% Stable
Earnings Quality50/100 · Moderate
OPM stable around 11% Steady
Quarterly Momentum60/100 · Moderate
Revenue (4Q): +22% YoY AcceleratingProfit (4Q): -18% YoY Declining
Industry Rank65/100 · Strong
P/E 17.5 vs industry 53.8 Cheaper than peersROCE 17.2% vs industry 16.4% Average3Y sales CAGR: 11% Moderate

Weights: Health 30% · Earnings Quality 25% · Momentum 20% · Industry Rank 15% · Smart Money 10%. Scores are computed from reported financials and recalculated daily. Not investment advice.

Share Price and Basic Stock Data

Last Updated: April 2, 2026, 4:06 am

Market Cap 731 Cr.
Current Price 73.0
Intrinsic Value₹53.65
High / Low 115/66.7
Stock P/E17.5
Book Value 32.6
Dividend Yield2.06 %
ROCE17.2 %
ROE13.4 %
Face Value 5.00
PEG Ratio2.71

Stock P/E, Current Price, and Intrinsic Value Over Time

View Share Price Target for Anuh Pharma Ltd

Competitors

Stock Name ⇩Market Cap ⇩Current Price ⇩High / Low ⇩Stock P/E ⇩Book Value ⇩Dividend Yield ⇩ROCE ⇩ROE ⇩Face Value ⇩
Anuh Pharma Ltd 731 Cr. 73.0 115/66.717.5 32.62.06 %17.2 %13.4 % 5.00
Themis Medicare Ltd 683 Cr. 74.2 179/65.0 41.30.67 %10.4 %7.65 % 1.00
Wanbury Ltd 805 Cr. 230 330/16218.7 18.10.00 %36.7 %76.5 % 10.0
Kopran Ltd 574 Cr. 119 215/10734.7 1042.53 %9.75 %7.64 % 10.0
Fredun Pharmaceuticals Ltd 939 Cr. 1,716 1,999/63527.6 2940.04 %18.9 %15.8 % 10.0
Industry Average19,815.15 Cr1,053.8453.84201.200.39%16.35%15.16%6.10

All Competitor Stocks of Anuh Pharma Ltd

Quarterly Result

MetricDec 2022Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025
Sales 139157161150172164138166160198186186197
Expenses 126143148132148145127149145179176174180
Operating Profit 12141418241911171519101217
OPM % 9%9%9%12%14%12%8%10%9%9%6%6%9%
Other Income 2132434311314
Interest 0000000000000
Depreciation 2222222223333
Profit before tax 12131518252012181317111018
Tax % 23%25%24%23%24%22%22%17%22%28%24%23%25%
Net Profit 91012141915101510128813
EPS in Rs 0.930.961.171.381.911.530.951.501.031.240.830.761.34

Last Updated: March 3, 2026, 12:23 pm

Quarterly Chart

Profit & Loss - Annual Report

Last Updated: February 26, 2026, 8:16 pm

MetricMar 2014Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025TTM
Sales 266284326206238321307432487527647662768
Expenses 242253289183220291284387439476571600710
Operating Profit 24313823183023454752766258
OPM % 9%11%12%11%8%9%8%10%10%10%12%9%8%
Other Income 4548754115612910
Interest 1111011221110
Depreciation 23222271512109911
Profit before tax 25323828233219393947786156
Tax % 31%31%32%27%29%28%25%26%22%24%23%22%
Net Profit 18222620172314283136604742
EPS in Rs 1.762.192.572.001.652.331.432.843.053.615.994.734.17
Dividend Payout % 37%27%24%31%42%29%48%26%29%28%21%16%

Profit & Loss Yearly Chart

YoY Net Profit Growth

Year2014-20152015-20162016-20172017-20182018-20192019-20202020-20212021-20222022-20232023-20242024-2025
YoY Net Profit Growth (%)22.22%18.18%-23.08%-15.00%35.29%-39.13%100.00%10.71%16.13%66.67%-21.67%
Change in YoY Net Profit Growth (%)0.00%-4.04%-41.26%8.08%50.29%-74.42%139.13%-89.29%5.41%50.54%-88.33%

Anuh Pharma Ltd has shown an inconsistent trend in YoY Net Profit Growth (%) in the last 11 years from 2014-2015 to 2024-2025.

Growth

Compounded Sales Growth
10 Years:9%
5 Years:17%
3 Years:11%
TTM:14%
Compounded Profit Growth
10 Years:7%
5 Years:26%
3 Years:13%
TTM:-20%
Stock Price CAGR
10 Years:2%
5 Years:-3%
3 Years:21%
1 Year:-17%
Return on Equity
10 Years:14%
5 Years:15%
3 Years:16%
Last Year:13%

Last Updated: September 5, 2025, 2:21 pm

Balance Sheet

Last Updated: February 1, 2026, 4:18 am

MonthMar 2014Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Sep 2025
Equity Capital 441313131313252525252550
Reserves 8297107128137152150166189216266301277
Borrowings 0020244514413110
Other Liabilities 776771485771119128129163152170182
Total Liabilities 163168193189209240326333347405446507509
Fixed Assets 1291817172184716153495861
CWIP 00006340000001
Investments 274343706639803143919710671
Other Assets 124116131101120147163230243261300342376
Total Assets 163168193189209240326333347405446507509

Reserves and Borrowings Chart

Cash Flow

MonthMar 2014Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025
Cash from Operating Activity + 151916262749-1929541337
Cash from Investing Activity + -5-12-5-2023-7752-8-431-20
Cash from Financing Activity + -8-8-9-4-5-722-33-19-12-9-5
Net Cash Flow 2-122-13-502-2512
Free Cash Flow 1418625-5-2213-252752817
CFO/OP 86%96%78%149%49%56%232%-20%80%130%42%78%

Free Cash Flow

MonthMar 2014Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025
Free Cash Flow24.0031.0036.0023.0016.0026.00-22.0031.0043.0051.0073.0051.00

Free Cash Flow = Income Generated from Operational Activities - Borrowings - Capital Work in Progress (CWIP)

Consistent positive free cash flow is crucial for businesses as it indicates their ability to generate cash from their core operations. It provides financial flexibility, allowing companies to invest in growth opportunities, pay dividends to shareholders, reduce debt, and weather economic downturns more effectively.

Free Cash Flow Chart

Financial Efficiency Indicators

MonthMar 2014Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025
Debtor Days 1028884100109859690102118107119
Inventory Days 332735726464989077665754
Days Payable 102797710210589166133117139105115
Cash Conversion Cycle 333642706861284862465859
Working Capital Days 424348798065-105768616968
ROCE %31%33%35%19%14%19%10%16%18%19%26%17%

Financial Efficiency Indicators Chart

Share Holding Pattern

MonthMar 2023Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025
Promoters 70.59%70.59%70.59%69.94%69.91%69.91%69.91%69.91%69.91%69.91%71.81%71.81%
FIIs 0.00%0.00%0.00%0.00%0.03%0.03%0.02%0.02%0.04%0.04%0.00%0.00%
DIIs 0.00%0.00%0.00%0.00%0.10%0.00%0.00%0.00%0.00%0.00%0.00%0.00%
Public 29.40%29.39%29.40%30.05%29.96%30.05%30.06%30.07%30.04%30.04%28.19%28.17%
No. of Shareholders 19,96919,42319,06620,51922,23723,49423,91024,27924,23524,25728,25027,889

Shareholding Pattern Chart

No. of Shareholders

Anuh Pharma Ltd: Intrinsic Value & Share Price Analysis - Shareholder trend analysis

This stock is not held by any mutual fund.

ROCE Trend

EPS Trend

Key Financial Ratios

MonthMar 25Mar 24Mar 23Mar 22Mar 21
FaceValue 5.005.005.005.005.00
Basic EPS (Rs.) 9.4511.987.226.105.67
Diluted EPS (Rs.) 9.4511.987.226.105.67
Cash EPS (Rs.) 11.1913.709.158.488.68
Book Value[Excl.RevalReserv]/Share (Rs.) 65.0658.1148.1442.6638.04
Book Value[Incl.RevalReserv]/Share (Rs.) 65.0658.1148.1442.6638.04
Dividend / Share (Rs.) 1.502.502.001.751.50
Revenue From Operations / Share (Rs.) 132.01129.11105.2697.1186.20
PBDIT / Share (Rs.) 14.0417.4111.4510.3911.00
PBIT / Share (Rs.) 12.3015.709.528.007.99
PBT / Share (Rs.) 12.1715.639.477.817.69
Net Profit / Share (Rs.) 9.4511.987.226.105.67
PBDIT Margin (%) 10.6313.4810.8710.6912.76
PBIT Margin (%) 9.3112.159.048.239.27
PBT Margin (%) 9.2212.108.998.038.92
Net Profit Margin (%) 7.159.286.856.276.58
Return on Networth / Equity (%) 14.5220.6214.9914.2914.91
Return on Capital Employeed (%) 18.7826.8419.5718.5320.73
Return On Assets (%) 9.3413.478.938.808.54
Total Debt / Equity (X) 0.030.010.000.010.07
Asset Turnover Ratio (%) 1.391.521.401.431.31
Current Ratio (X) 2.112.201.911.981.70
Quick Ratio (X) 1.691.711.461.371.12
Inventory Turnover Ratio (X) 8.838.744.944.364.53
Dividend Payout Ratio (NP) (%) 26.4516.6824.2324.590.00
Dividend Payout Ratio (CP) (%) 22.3314.6019.1117.670.00
Earning Retention Ratio (%) 73.5583.3275.7775.410.00
Cash Earning Retention Ratio (%) 77.6785.4080.8982.330.00
Interest Coverage Ratio (X) 113.62246.74262.7754.1636.88
Interest Coverage Ratio (Post Tax) (X) 77.46170.85166.6632.8020.03
Enterprise Value (Cr.) 736.681223.09392.34417.88446.02
EV / Net Operating Revenue (X) 1.111.890.740.851.03
EV / EBITDA (X) 10.4714.026.848.038.09
MarketCap / Net Operating Revenue (X) 1.131.900.750.881.05
Retention Ratios (%) 73.5483.3175.7675.400.00
Price / BV (X) 2.294.231.652.012.37
Price / Net Operating Revenue (X) 1.131.900.750.881.05
EarningsYield 0.060.040.090.070.06

Profitability Ratios (%)

Liquidity Ratios

Liquidity Ratios (%)

Interest Coverage Ratios (%)

Valuation Ratios

About the Company - Qualitative Analysis

Anuh Pharma Ltd. is a Public Limited Listed company incorporated on 19/02/1960 and has its registered office in the State of Maharashtra, India. Company's Corporate Identification Number(CIN) is L24230MH1960PLC011586 and registration number is 011586. Currently Company is involved in the business activities of Manufacture of pharmaceuticals, medicinal chemical and botanical products. Company's Total Operating Revenue is Rs. 661.51 Cr. and Equity Capital is Rs. 25.06 Cr. for the Year ended 31/03/2025.
INDUSTRYADDRESSCONTACT
Pharmaceuticals3-A, Shivsagar Estate, Mumbai Maharashtra 400018Contact not found
Management
NamePosition Held
Mr. Arun TodarwalChairman & Non-Exe.Director
Mr. Bipin N ShahVice Chairman & Non Exe.Dire
Mr. Ritesh B ShahJoint Managing Director
Mr. Vivek B ShahJoint Managing Director
Mr. Bharat ShahNon Executive Director
Mr. Samir ShahNon Executive Director
Mr. Gaurav S ShahNon Executive Director
Mr. Ketan ShahNon Executive Director
Dr.(Ms.) Mita DixitIndependent Director
Mr. Siddharth J ShahIndependent Director
Mr. Pradeep H ThakurIndependent Director
Mr. Harmanbhai PatelIndependent Director

FAQ

What is the intrinsic value of Anuh Pharma Ltd and is it undervalued?

As of 10 April 2026, Anuh Pharma Ltd's intrinsic value is ₹53.65, which is 26.51% lower than the current market price of ₹73.00, suggesting the stock is overvalued. This is calculated using the PE ratio method factoring in ROE (13.4 %), book value (₹32.6), dividend yield (2.06 %), and 5-year EPS CAGR.

What is the current share price and 52-week range of Anuh Pharma Ltd?

Anuh Pharma Ltd is trading at ₹73.00 as of 10 April 2026, with a FY2026-2027 high of ₹115 and low of ₹66.7. The stock is currently near its 52-week low. Market cap stands at ₹731 Cr..

How does Anuh Pharma Ltd's P/E ratio compare to its industry?

Anuh Pharma Ltd has a P/E ratio of 17.5, which is below the industry average of 53.84. Trading at a steep discount to peers could signal a value opportunity or reflect concerns about the company's fundamentals.

Is Anuh Pharma Ltd financially healthy?

Key indicators for Anuh Pharma Ltd: ROCE of 17.2 % indicates efficient capital utilization. Dividend yield is 2.06 %.

Is Anuh Pharma Ltd profitable and how is the profit trend?

Anuh Pharma Ltd reported a net profit of ₹47 Cr in Mar 2025 on revenue of ₹662 Cr. Compared to ₹31 Cr in Mar 2022, the net profit shows an improving trend.

Does Anuh Pharma Ltd pay dividends?

Anuh Pharma Ltd has a dividend yield of 2.06 % at the current price of ₹73.00. This is a relatively attractive yield for income-seeking investors.

Disclaimer: This article is for informational purposes only and should not be construed as financial advice. The author is not a SEBI registered financial advisor and does not have any vested interest in Anuh Pharma Ltd. Investors are advised to conduct their own due diligence and consult with a financial professional before making any investment decisions. The information provided in this article is based on publicly available data and the author's analysis, but it may not be comprehensive or up-to-date. The author and getaka.co.in are not responsible for any errors or omissions in the content. This article is not intended to promote any particular investment strategy or recommendation, and readers should consult with their own financial advisors before making any investment decisions. Data Source: NSE
Explore Industry-wise Stock Analysis Reports